Cargando…

Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies

The complement system is crucial for defense against pathogens and the removal of dying cells or immune complexes. Thus, clinical indications for possible complete complement deficiencies include, among others, recurrent mild or serious bacterial infections as well as autoimmune diseases (AID). The...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Sissy, Carine, Rosain, Jérémie, Vieira-Martins, Paula, Bordereau, Pauline, Gruber, Aurélia, Devriese, Magali, de Pontual, Loïc, Taha, Muhamed-Kheir, Fieschi, Claire, Picard, Capucine, Frémeaux-Bacchi, Véronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694794/ https://www.ncbi.nlm.nih.gov/pubmed/31440263 http://dx.doi.org/10.3389/fimmu.2019.01936

Ejemplares similares

Complement and the atypical hemolytic uremic syndrome in children
por: Loirat, Chantal, et al.
Publicado: (2008)

Disseminated Cryptococcosis Following Eculizumab Therapy: Insight Into Pathogenesis
por: Lortholary, Olivier, et al.
Publicado: (2023)

The Rational Use of Complement Inhibitors in Kidney Diseases
por: Fakhouri, Fadi, et al.
Publicado: (2022)

Complement System Part I – Molecular Mechanisms of Activation and Regulation
por: Merle, Nicolas S., et al.
Publicado: (2015)

Complement System Part II: Role in Immunity
por: Merle, Nicolas S., et al.
Publicado: (2015)

Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
por: Boussier, Jeremy, et al.
Publicado: (2022)

Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside
por: Meuleman, Marie-Sophie, et al.
Publicado: (2022)

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice
por: Delmas, Yahsou, et al.
Publicado: (2013)

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice
por: Delmas, Yahsou, et al.
Publicado: (2013)

Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System
por: Pedersen, Dennis V., et al.
Publicado: (2019)

COVID-19 as a potential trigger of complement-mediated atypical HUS
por: El Sissy, Carine, et al.
Publicado: (2021)

Blockade of Alternative Complement Pathway in Dense Deposit Disease
por: Berthe-Aucejo, Aurore, et al.
Publicado: (2014)

Treatment of atypical uraemic syndrome in the era of eculizumab
por: Fremeaux-Bacchi, Veronique
Publicado: (2012)

Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)

Changing patterns of invasive meningococcal disease and future immunization strategies
por: Taha, Muhamed-Kheir, et al.
Publicado: (2023)

Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report
por: Bally, Stéphane, et al.
Publicado: (2019)

Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS
por: Ermini, Luca, et al.
Publicado: (2012)

Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort
por: Salmon, Jane E., et al.
Publicado: (2011)

Complement C3 is a novel modulator of the anti-factor VIII immune response
por: Rayes, Julie, et al.
Publicado: (2018)

Activation de la voie alterne du complément dans les formes sévères de COVID-19
por: Boussier, J., et al.
Publicado: (2021)

Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
por: El Karoui, Khalil, et al.
Publicado: (2019)

Complement inhibition in severe COVID-19 – Blocking C5a seems to be key: Author's reply
por: Annane, Djillali, et al.
Publicado: (2021)

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
por: Taha, Muhamed-Kheir, et al.
Publicado: (2020)

Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review
por: Deghmane, Ala-Eddine, et al.
Publicado: (2021)

Product review on the IMD serogroup B vaccine Bexsero®
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France
por: Taha, Samy, et al.
Publicado: (2022)

Acute Presentation and Persistent Glomerulonephritis Following Streptococcal Infection in a Patient With Heterozygous Complement Factor H–Related Protein 5 Deficiency
por: Vernon, Katherine A., et al.
Publicado: (2012)

Resistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins
por: Zapun, André, et al.
Publicado: (2016)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
por: Hong, Eva, et al.
Publicado: (2016)

Eculizumab and drug-induced haemolytic–uraemic syndrome
por: Faguer, Stanislas, et al.
Publicado: (2013)

A case of adult atypical haemolytic uraemic syndrome related to anti-factor H autoantibodies successfully treated by plasma exchange, corticosteroids and rituximab
por: Lionet, Arnaud, et al.
Publicado: (2009)

Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients
por: Audemard-Verger, A., et al.
Publicado: (2016)

Diffuse Endocapillary Glomerulonephritis in a Child With IL-17RA Deficiency Emphasizes the Pivotal Role of the Complement Cascade and Anaphylatoxins
por: d’Izarny-Gargas, Thibaut, et al.
Publicado: (2023)

Ciprofloxacin Resistance in Neisseria meningitidis, France
por: Skoczynska, Anna, et al.
Publicado: (2008)

Role of transition metal exporters in virulence: the example of Neisseria meningitidis
por: Guilhen, Cyril, et al.
Publicado: (2013)

Evidence for Multi-Organ Infection During Experimental Meningococcal Sepsis due to ST-11 Isolates in Human Transferrin-Transgenic Mice
por: Levy, Michael, et al.
Publicado: (2020)

Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis
por: Deghmane, Ala-Eddine, et al.
Publicado: (2023)

Complement C5 inhibition in patients with COVID- 19 - a promising target?
por: de Latour, Regis Peffault, et al.
Publicado: (2020)

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
por: Chauvet, Sophie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lrunqfn7f6esju9oug0105raln